Alliancebernstein L.P. I Bio, Inc. Transaction History

Alliancebernstein L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.23 - $0.46 $31,441 - $62,882	-136,700 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$0.3 - $0.61 $270 - $549	900 Added 0.66%	136,700 $59,000
Q2 2021 Jul 30, 2021	BUY	$1.22 - $1.65 $55,510 - $75,075	45,500 Added 50.39%	135,800 $205,000
Q4 2020 Feb 08, 2021	SELL	$1.05 - $2.24 $90,195 - $192,416	-85,900 Reduced 48.75%	90,300 $95,000
Q2 2020 Aug 13, 2020	BUY	$0.87 - $2.46 $153,294 - $433,452	176,200 New	176,200 $391,000

Ticker IBIO
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,006,580
Market Cap $24M
Description
iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.